VIPDOMET 12.5/1000; 12.5 mg alogliptin (as benzoate) / 1000 mg metformin hydrochloride film-coated tablets blister pack

Maa: Australia

Kieli: englanti

Lähde: Department of Health (Therapeutic Goods Administration)

Aktiivinen ainesosa:

metformin hydrochloride, Quantity: 1000 mg; alogliptin benzoate, Quantity: 17 mg (Equivalent: alogliptin, Qty 12.5 mg)

Saatavilla:

Takeda Pharmaceuticals Australia Pty Ltd

INN (Kansainvälinen yleisnimi):

Alogliptin benzoate,Metformin hydrochloride

Lääkemuoto:

Tablet, film coated

Koostumus:

Excipient Ingredients: mannitol; purified talc; iron oxide yellow; povidone; microcrystalline cellulose; magnesium stearate; titanium dioxide; crospovidone; hypromellose

Antoreitti:

Oral

Kpl paketissa:

120, 112, 180, 56, 60, 14, 10, 196, 28, 98, 200, 20

Prescription tyyppi:

(S4) Prescription Only Medicine

Käyttöaiheet:

VIPDOMET is indicated to improve glycaemic control in adult patients (> or = 18 years old) with type 2 diabetes mellitus when diet and exercise do not provide adequate glycaemic control and treatment with both alogliptin and metformin is appropriate,,- when treatment with metformin alone does not provide adequate control; or - in combination with a thiazolidinedione or with insulin, when dual therapy does not provide adequate control.,VIPDOMET can also be used to replace separate tablets of alogliptin and metformin in patients already being treated with this combination.

Tuoteyhteenveto:

Visual Identification: Pale yellow, oblong, biconvex, film-coated tablets with 12.5/1000 debossed on one side and 322M debossed on the other side.; Container Type: Blister Pack; Container Material: PVC/PCTFE (Aclar)/Al; Container Life Time: 36 Months; Container Temperature: Store below 25 degrees Celsius

Valtuutuksen tilan:

Registered

Valtuutus päivämäärä:

2013-10-22